MDGL Stock Price History and Quote Analysis Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own MDGL shares is 358, representing 104.39% of the company's common stock.

ALLIANCEBERNSTEIN L.P., in the last quarter, reduced its stake in MDGL by -91.79% restricting it's holding to 27.9 thousand shares of worth nearly $7.45M. BLACKROCK INC. also lessened -0.18% of the MDGL shares from its portfolio, reducing its holding to 1.21 million shares of worth $323.22M. STATE STREET CORP also shunned MDGL shares holding by -10.82% last quarter which brought its holding to 624.94 thousand shares worth $166.88M.

As per its latest 13F filing, FRED ALGER MANAGEMENT, LLC increased its stake in MDGL by 256.83% in the last quarter. The institutional holder raised its holding to 64.58 thousand shares having worth more than $17.24M. SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) also added 566.01% more shares of MDGL to its portfolio, raising its holding to 35.11 thousand shares of worth $9.38M. CITIGROUP INC also increased its MDGL shares holding by 53.78% which brought its holding to 32.79 thousand shares worth $8.76M.

The insider with the most stakes in MDGL is N/A , N/A at the company. Additionally, MDGL stock is highly held by N/A N/A and N/A N/A among others.

Company executives, directors, and other insiders own 14.81% percent of Madrigal Pharmaceuticals, Inc.'s stock. Within the last six months, there have been 7 transaction(s) in which MDGL insiders have sold stock, totaling 17.45K shares. Insiders that have sold shares include CRAVES FRED B, HUNTSMAN CAROLE, and LEVY RICHARD S.

There have been 0 transaction(s) during the past 6-months in which Madrigal Pharmaceuticals, Inc. insiders have bought stock, totalling 0 shares

Around 114.3K Madrigal Pharmaceuticals, Inc. shares are held by insiders, which represents about 14.81% of MDGL stock.

MDGL N/A, N/A holds the largest portfolio of the company's shares. MDGL shares owned by N/A total nearly -.

FRED ALGER MANAGEMENT, LLC is the largest institutional owner in MDGL which holds 64.58 thousand shares worth $17.24M or 0.32% of the total MDGL shares outstanding followed by SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) with ownership of 35.11 thousand shares representing 0.18% of the MDGL ownership. CITIGROUP INC is the third largest stakeholder with 32.79 thousand shares or 0.17% of the ownership worth more than $8.76M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the MDGL is concerned, it is a stock which is optionable.

Number of MDGL shares short is 4.05M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 21.81M shares of MDGL are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, MDGL has 10.73M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for MDGL is 14.17.